re: Ann: AED to commence well test on Lempuya... This looks promising. And probably explains the build up on the buy side today. The bargain hunters are moving in.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%